top of page

Acerca de

April 2026 Report

In April 2026, the foundation continued supporting Ukrainian military personnel by providing units with the necessary medicines and medical supplies in accordance with current requests. During the month, assistance was received by the units of the Special Operations Forces, the 79th Separate Mechanized Brigade, and the 82nd Brigade.

 

The total amount of assistance for the month amounted to $2,806.34.

 

For the Special Operations Forces of the Armed Forces of Ukraine, we purchased:

 

Reosorbilact 200 — 96 pcs., $292.41

Sorbitolact 200 — 48 pcs., $177.43

Tivortin for infusions 100 + oral — 60 pcs., $302.83

Xylat 200 — 20 pcs., $92.09

Sufer — 2 pcs., $57.77

Analgin №10 — 10 pcs., $21.98

Kaidex №5 — 20 pcs., $77.68

Hekodez 200 — 20 pcs., $109.79

GIK — 5 pcs., $16.26

Volotenz vials — 30 pcs., $199.92

Trisol 200 — 30 pcs., $37.09

 

These purchases were aimed at providing the unit with medicines for infusion therapy, body support, and emergency medical care.

 

For the 79th Separate Mechanized Brigade, we purchased:

 

Mediatron injection solution — 20 pcs., $418.08

Mediatron tablets 20 ml №50 — 10 pcs., $153.67

Xefocam 8 mg vial №5 — 10 pcs., $185.76

Larfix tablets 8 mg №100 — 3 pcs., $105.97

Mexicor capsules 100 mg — 5 pcs., $46.51

 

For the 82nd Separate Air Assault Brigade, we purchased:

 

Neovitam — 5 pcs., $58.14

Lidocaine spray — 10 pcs., $29.17

Sterofundin ISO — 30 pcs., $139.16

Ototon ear drops — 12 pcs., $131.56

Ciprofarm — 500 pcs., $48.48

Disposable infusion sets — 30 pcs., $104.59

 

This supply makes it possible to maintain the stable operation of medical units and promptly respond to the needs of military personnel.

 

We sincerely thank everyone who supports the foundation’s activities. Thanks to your contributions, we are able to purchase the necessary medicines in a timely manner and deliver them where they are needed most.

 

Together, we continue to support Ukrainian defenders and help those who defend Ukraine every day!

  • LinkedIn
  • Facebook
bottom of page